Lonza Group AG

Sector: Pharmaceutical Preparations Region: Switzerland

Exchange/Ticker: OTC Bulletin Board: LZAGF | Frankfurt Stock Exchange: LO3 | OTC Bulletin Board: LZAGY | SIX Swiss Exchange: LONN

Company Description

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It provides value chemical and biotech ingredients to the nutrition and agro markets. The company operates its business through four segments: Custom Manufacturing, Life Science Ingredients, Microbial Control, and Bioscience. The Custom Manufacturing segment is the partner to pharmaceutical and biopharmaceutical customers for their manufacturing needs. The Life Science Ingredients segment offers products used in nutrition, microbial control, and in selected industrial markets. The Microbial Control segment offers customers complete solutions for their microbial control needs, which deals with hygiene and preservation, water treatment, materials protection, personal care and wood treatment. The Bioscience segment offers tools that life-science customers use to discover, develop, make, and test therapeutics. It engages in the large and small molecules, peptides, amino acids and niche bio products. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Similar to: Trius Therapeutics, Inc., AstraZeneca Plc, Columbia Laboratories, Inc.

Featured Company

Aberdeen Private Equity Fund Ltd.

London, Guernsey , GG

**Objective of Aberdeen Private Equity Fund** The investment objective of the Company is to generate long-term capital gains. … Learn more →